Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma
Clinical trial NCT02928029 · TERMINATED
Trial details
- NCT number
- NCT02928029
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-10
- Primary completion
- 2019-03-20
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.